Quick Answer
Entera Bio Ltd. reported R&D Expense of $6.00 million for fiscal year 2025.
Entera Bio Ltd. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $6.00M | +33.5% |
| 2024 | $4.50M | -0.2% |
| 2023 | $4.51M | -22.9% |
| 2022 | $5.85M | -13.6% |
| 2021 | $6.77M | +6.1% |
| 2020 | $6.38M | -11.3% |
| 2019 | $7.20M | -15.5% |
| 2018 | $8.52M | +207.7% |
| 2017 | $2.77M | +4.5% |
| 2016 | $2.65M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.64M | +11.2% | +8.1% |
| June 30, 2025 | $1.52M | +40.0% | +35.4% |
| March 31, 2025 | $1.12M | +52.8% | -24.0% |
| September 30, 2024 | $1.48M | +7.8% | +36.0% |
| June 30, 2024 | $1.09M | -10.2% | +47.8% |
| March 31, 2024 | $735.0K | -21.1% | -46.4% |
| September 30, 2023 | $1.37M | -3.0% | +13.3% |
| June 30, 2023 | $1.21M | -13.3% | +29.9% |
- Entera Bio Ltd. showed an increase of +33.5% in R&D Expense compared to the prior fiscal year.
- Over the 2016–2025 period, Entera Bio Ltd.’s r&d expense has grown by 126.7% (from $2.65 million to $6.00 million).
- The most recent figure is from Entera Bio Ltd.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: